In vivo activities of newer rifamycin analogs against Mycobacterium avium infection

In vivo activities of newer rifamycin analogs against Mycobacterium avium infection

Item
http://www.wikidata.org/entity/Q28322002
Q28346135
sameAs
Activity of azithromycin against Mycobacterium avium infection in beige miceActivity of clarithromycin against Mycobacterium avium complex infection in beige miceEffectiveness of various antimicrobial agents against Mycobacterium avium complex in the beige mouse modelComparative activities of azithromycin and clarithromycin against Mycobacterium avium infection in beige miceIntermittent azithromycin for treatment of Mycobacterium avium infection in beige miceActivity of KRM 1648 alone or in combination with ethambutol or clarithromycin against Mycobacterium avium in beige mouse model of disseminated infectionComparative in vivo activities of rifabutin and rifapentine against Mycobacterium avium complexAzithromycin, rifabutin, and rifapentine for treatment and prophylaxis of Mycobacterium avium complex in rats treated with cyclosporineBacteriostatic and bactericidal activities of benzoxazinorifamycin KRM-1648 against Mycobacterium tuberculosis and Mycobacterium avium in human macrophagesAnticytomegaloviral activity of methotrexate associated with preferential accumulation of drug by cytomegalovirus-infected cellsHow effective is KRM-1648 in treatment of disseminated Mycobacterium avium complex infections in beige mice?Activities of bay Y 3118, levofloxacin, and ofloxacin alone or in combination with ethambutol against Mycobacterium avium complex in vitro, in human macrophages, and in beige miceBeige mouse model for Mycobacterium avium complex disease.Inactivation of rifampin by Nocardia brasiliensis.Efficacy of rifabutin-loaded microspheres for treatment of Mycobacterium avium-infected macrophages and mice.Is rifabutin prophylaxis against Mycobacterium avium complex infection in HIV infection worthwhile? The net impact on patients suggests not.
P2860

In vivo activities of newer rifamycin analogs against Mycobacterium avium infection

Item
http://www.wikidata.org/entity/Q28322002
description
1991 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1991 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 1991
@ast
im Oktober 1991 veröffentlichter wissenschaftlicher Artikel
@de
scientific article (publication date: October 1991)
@en
vedecký článok (publikovaný 1991-10)
@sk
vědecký článek publikovaný v roce 1991
@cs
wetenschappelijk artikel (gepubliceerd in 1991-10)
@nl
наукова стаття, опублікована в жовтні 1991
@uk
научни чланак (објављен 1991-10)
@sr
name
In vivo activities of newer rifamycin analogs against Mycobacterium avium infection
@ast
In vivo activities of newer rifamycin analogs against Mycobacterium avium infection
@en
In vivo activities of newer rifamycin analogs against Mycobacterium avium infection
@nl
type
label
In vivo activities of newer rifamycin analogs against Mycobacterium avium infection
@ast
In vivo activities of newer rifamycin analogs against Mycobacterium avium infection
@en
In vivo activities of newer rifamycin analogs against Mycobacterium avium infection
@nl
prefLabel
In vivo activities of newer rifamycin analogs against Mycobacterium avium infection
@ast
In vivo activities of newer rifamycin analogs against Mycobacterium avium infection
@en
In vivo activities of newer rifamycin analogs against Mycobacterium avium infection
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P698
P932
P356
P1433
P1476
In vivo activities of newer rifamycin analogs against Mycobacterium avium infection
@en
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P698
P932